{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:46:37Z","timestamp":1781894797859,"version":"3.54.5"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0111877","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T19:14:12Z","timestamp":1415128452000},"page":"e111877","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome"],"prefix":"10.1371","volume":"9","author":[{"given":"Imen","family":"Medimegh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Omrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Privat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Uhrhummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajer","family":"Ayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadoua","family":"Belaiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat","family":"Benayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Benromdhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ives-Jean","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel Benammar","family":"Elgaaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5858\/arpa.2012-0439-RA","article-title":"Basal-like breast cancer: update on clinicopathologic, immunohistochemical, and molecular features","volume":"138","author":"J Leidy","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ejca.2014.02.022","article-title":"Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial","volume":"50","author":"AS Knoop","year":"2014","journal-title":"Eur J Cancer"},{"key":"ref4","first-page":"81","article-title":"Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival","volume":"8","author":"JJ Maly","year":"2014","journal-title":"Breast Cancer (Auckl)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10549-012-2002-z","article-title":"Invasive lobular breast cancer: subtypes and outcome","volume":"133","author":"M Iorfida","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Vormoor B, Curtin NJ (2014) Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma. Curr Opin Oncol.","DOI":"10.1097\/CCO.0000000000000091"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Park HS, Jang MH, Kim EJ, Kim HJ, Lee HJ, et al.. (2014) High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. Mod Pathol.","DOI":"10.1038\/modpathol.2013.251"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/onc.2012.572","article-title":"Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer","volume":"33","author":"JC Montero","year":"2014","journal-title":"Oncogene"},{"key":"ref9","unstructured":"Jaitak V (2014) Drug Target Strategies in Breast Cancer Treatment: Recent Developments. Anticancer Agents Med Chem."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/PAI.0b013e318286030d","article-title":"Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal fibroblasts","volume":"22","author":"JA Niemiec","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamasurg.2013.3181","article-title":"Personalizing breast cancer staging by the inclusion of ER, PR, and HER2","volume":"149","author":"SP Bagaria","year":"2014","journal-title":"JAMA Surg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12094-013-1070-9","article-title":"Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)","volume":"16","author":"R Andres","year":"2014","journal-title":"Clin Transl Oncol"},{"key":"ref13","first-page":"396","article-title":"The African Organisation for Research and Training in Cancer and its conferences: a historical perspective and highlights of the Ninth International Conference, Durban, South Africa, 21\u201324 November 2013","volume":"8","author":"CK Williams","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5306\/wjco.v5.i2.71","article-title":"Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?","volume":"5","author":"GS Christodoulatos","year":"2014","journal-title":"World J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1096\/fj.13-242230","article-title":"Carbon ion radiotherapy of human lung cancer attenuates HIF-1 signaling and acts with considerably enhanced therapeutic efficiency","volume":"28","author":"FS Subtil","year":"2014","journal-title":"FASEB J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/CMAR.S53928","article-title":"MicroRNA function and dysregulation in bone tumors: the evidence to date","volume":"6","author":"M Nugent","year":"2014","journal-title":"Cancer Manag Res"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Puppin C, Durante C, Sponziello M, Verrienti A, Pecce V, <etal>et al<\/etal>.. (2014) Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation. Endocrine.","DOI":"10.1007\/s12020-014-0204-3"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ijo.2013.2059","article-title":"From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review)","volume":"43","author":"R Piva","year":"2013","journal-title":"Int J Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/wrna.1229","article-title":"MicroRNAs as therapeutic targets in human cancers","volume":"5","author":"MY Shah","year":"2014","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4161\/cc.10.11.15777","article-title":"MicroRNA signatures differentiate melanoma subtypes","volume":"10","author":"E Chan","year":"2011","journal-title":"Cell Cycle"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.1304977110","article-title":"Prognostic microRNA\/mRNA signature from the integrated analysis of patients with invasive breast cancer","volume":"110","author":"S Volinia","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e96698","DOI":"10.1371\/journal.pone.0096698","article-title":"The Repressive Effect of miR-148a on TGF beta-SMADs Signal Pathway Is Involved in the Glabridin-Induced Inhibition of the Cancer Stem Cells-Like Properties in Hepatocellular Carcinoma Cells","volume":"9","author":"F Jiang","year":"2014","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Varendi K, Kumar A, Harma MA, Andressoo JO (2014) miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF. Cell Mol Life Sci.","DOI":"10.1007\/s00018-014-1628-x"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/carcin\/bgt160","article-title":"MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression","volume":"34","author":"K Zhu","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.urolonc.2011.07.002","article-title":"MicroRNA expression profiles in the progression of prostate cancer\u2013from high-grade prostate intraepithelial neoplasia to metastasis","volume":"31","author":"KR Leite","year":"2013","journal-title":"Urol Oncol"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Fritz HK, Lindgren D, Ljungberg B, Axelson H, Dahlback B (2014) The miR ratio as a prognostic marker in clear cell renal cell carcinoma. Eur J Cancer.","DOI":"10.1016\/j.ejca.2014.03.281"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","article-title":"Tumour invasion and metastasis initiated by microRNA-10b in breast cancer","volume":"449","author":"L Ma","year":"2007","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/ijc.24522","article-title":"MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC","volume":"125","author":"T Sasayama","year":"2009","journal-title":"Int J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"13414","DOI":"10.3390\/ijms131013414","article-title":"The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis","volume":"13","author":"J Tang","year":"2012","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000350131","article-title":"Decreased microRNA-221 is associated with high levels of TNF-alpha in human adipose tissue-derived mesenchymal stem cells from obese woman","volume":"32","author":"WW Chou","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"S Volinia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Calvano Filho CM, Calvano-Mendes DC, Carvalho KC, Maciel GA, Ricci MD, et al.. (2014) Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p. Tumour Biol.","DOI":"10.1007\/s13277-014-2025-7"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"18515","DOI":"10.1074\/jbc.M109.006676","article-title":"Up-regulation of miR-21 by HER2\/neu signaling promotes cell invasion","volume":"284","author":"TH Huang","year":"2009","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s12032-014-0977-5","article-title":"Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia","volume":"31","author":"N Petrovic","year":"2014","journal-title":"Med Oncol"},{"key":"ref35","first-page":"743","article-title":"Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA","volume":"25","author":"J Gao","year":"2013","journal-title":"Chin J Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/carcin\/bgq184","article-title":"Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1\/BRCA2-negative familial breast and ovarian cancer patients","volume":"31","author":"C Pastrello","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/emmm.201100136","article-title":"Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers","volume":"3","author":"AI Garcia","year":"2011","journal-title":"EMBO Mol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/mutage\/ges052","article-title":"The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies","volume":"27","author":"J Wang","year":"2012","journal-title":"Mutagenesis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1042\/BST0361211","article-title":"Role of miRNA-146a in the regulation of the innate immune response and cancer","volume":"36","author":"AE Williams","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"ref40","first-page":"210","article-title":"Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients","volume":"50","author":"S Kumar","year":"2013","journal-title":"Indian J Biochem Biophys"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/annonc\/mdu066.4","article-title":"23p * alternate epigenetic mechanism for the repression of brca1 in sporadic breast cancers mediated by mir182","volume":"25","author":"A Korlimarla","year":"2014","journal-title":"Ann Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/modpathol.2012.118","article-title":"Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma","volume":"25","author":"BD McMillen","year":"2012","journal-title":"Mod Pathol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.scitotenv.2010.06.029","article-title":"Time trends of persistent organic pollutants in Sweden during 1993\u20132007 and relation to age, gender, body mass index, breast-feeding and parity","volume":"408","author":"E Hardell","year":"2010","journal-title":"Sci Total Environ"},{"key":"ref44","first-page":"299","article-title":"Pregnancy and lactation in relation to breast cancer risk","volume":"3","author":"H Vorherr","year":"1979","journal-title":"Semin Perinatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/MCB.01395-06","article-title":"A microRNA signature of hypoxia","volume":"27","author":"R Kulshreshtha","year":"2007","journal-title":"Mol Cell Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0973-1482.77072","article-title":"Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway","volume":"6","author":"A Gokhale","year":"2010","journal-title":"J Cancer Res Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","article-title":"Oral contraceptives and breast cancer risk overall and by molecular subtype among young women","volume":"23","author":"EF Beaber","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Elebro K, Butt S, Dorkhan M, Jernstrom H, Borgquist S (2014) Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmo Diet and Cancer Cohort. Cancer Causes Control.","DOI":"10.1007\/s10552-014-0394-2"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0111877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T01:12:59Z","timestamp":1566004379000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0111877"}},"subtitle":[],"editor":[{"given":"Pranela","family":"Rameshwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0111877","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}